Skip to content
Research Article Open access CC BY 4.0

Interference of Heterophilic Antibody in D-dimer Determination in an Asymptomatic Elderly Woman

Valverde Sara, Masiero Elena, Seguso Mara, Giordano Martina, Inglese Margherita, Gessoni Gianluca

International Blood Research & Reviews · pp. 1–9 · Published 2 Apr 2024

10.9734/ibrr/2024/v15i2334

Abstract

Background: D-Dimer is considered a pivotal biomarker in diagnosis of disseminated intravascular coagulation and in differential diagnosis of thrombosis and pulmonary embolism. Case Summary: BL, Caucasian woman, 81 years old, was admitted to hospital, in October 2023, for concussive head trauma after an accidental fall. The patient had a "non-assayable D-Dimer due to excess antigen" utilizing Sysmex Innovance D-dimer using a Sysmex CS 5100 analyser. This abnormal result was firstly observed in March 2022. A second Laboratory confirmed the raised D-dimer concentration. The patient had undergone periodic D-dimer checks which had always confirmed the results and had been treated with a direct FXa inhibitor. Methods:  Patient’s samples were tested for D-dimer using different assays and different analysers, moreover sample diluted in phosphate buffer and heterophilic antibodies blocking reagent have been tested. Results: The Sysmex Innovance D-dimer assay gave us, constantly “non-assayable D-dimer due to excess antigen" results; the HemosIL D-dimer HS assay gave us, constantly a raised D-dimer concentration (four to five higher than upper reference values); the Quidel Triage D-dimer gave us, constantly  D-dimer normal concentration. Results obtained from dilution curves confirmed the presence of high concentration high avidity  heterophilic antibodies. Conclusions: Reports regarding the influence of heterophilic antibodies on the measurement of D‐dimer are quite uncommon in literature however, they constitute a significant potential risk. Interference from heterophile antibodies often has a different impact using different instruments and methods in the measurement of D‐dimer. Using a combination of different assays and analysers, of dilution strategy with heterophilic antibody blockers, and combining laboratory results with clinical examinations and imaging data, we were able to identify the interference and exclude the presence of thrombosis.

D‐dimer D‐dimer assays heterophilic antibody immunoassay interference

References (31)

  1. 1 Derivation of a Simple Clinical Model to Categorize Patients Probability of Pulmonary Embolism: Increasing the Models Utility with the SimpliRED D-dimer [DOI]
  2. 2 Value of assessment of pretest probability of deep-vein thrombosis in clinical management [DOI]
  3. 3 A Test in Context: D-Dimer [DOI]
  4. 4 Interferences in Immunoassay [DOI]
  5. 5 D-dimer: Preanalytical, analytical, postanalytical variables, and clinical applications [DOI]
  6. 6 Widely Used Types and Clinical Applications of D-Dimer Assay [DOI]
  7. 7 Verification of the ACL Top 50 Family (350, 550, and 750) for Harmonization of Routine Coagulation Assays in a Large Network of 60 Laboratories [DOI]
  8. 8 Methods for analyzing positive cardiac troponin assay interference [DOI]
  9. 9 Variability in D-dimer reporting revisited [DOI]
  10. 10 Formation and elimination of soluble fibrin and D-dimer in the bloodstream [DOI]
  11. 11 Analytical performance of a new immunoturbidimetric D‐dimer assay and comparison with available assays [DOI]
  12. 12 Influence of mechanical hemolysis of blood on two D-dimer immunoassays [DOI]
  13. 13 What makes D‐dimer assays suspicious–heterophilic antibodies? [DOI]
  14. 14 Interference from heterophilic antibodies in D-dimer assessment. A case report [DOI]
  15. 15 Hypeprolactinemia: still an insidious diagnosis [DOI]
  16. 16 False-positive D-dimer result in a latex-enhanced immunoassay caused by interfering human anti-mouse antibodies [DOI]
  17. 17 Interference of lipemia in samples for routine coagulation testing using a Sysmex CS‐5100 coagulometer [DOI]
  18. 18 Interference of D‐dimer levels from heterophilic antibody in COVID‐19: A serious concern in treatment and follow‐up of patients [DOI]
  19. 19 Diagnostic accuracy of the Triage® D-dimer test for exclusion of venous thromboembolism in outpatients [DOI]
  20. 20 Heterophilic antibody interference with TSH measurement on different immunoassay platforms [DOI]
  21. 21 Clinical laboratory investigation of a patient with an extremely high D-dimer level: A case report [DOI]
  22. 22 Identification of and solution for false D‐dimer results [DOI]
  23. 23 Persistent increase of carbohydrate antigen 19‐9 with an unknown reason: A seven‐year follow‐up case [DOI]
  24. 24 Interference of icterus on plasma D-dimer levels measured using immunoturbidimetric assays [DOI]
  25. 25 Falsely elevated D-dimer partially caused by heterophilic antibodies: A case report [DOI]
  26. 26 A case of benign immunoglobulin D monoclonal gammopathy of undetermined significance with 26 years of follow‐up [DOI]
  27. 27 Performance Evaluation of the Sysmex CS-5100 Automated Coagulation Analyzer [DOI]
  28. 28 D-dimers: a most misunderstood test [DOI]
  29. 29 Two Cases of Pseudoelevation of Plasma D-Dimer Levels [DOI]
  30. 30 The distribution of heterophilic antigens and their relationship with autoimmune diseases [DOI]
  31. 31 Discrepancies between two D-dimer assays and impact on clinical decisions; a retrospective analysis of samples tested in community and hospital-based laboratories in Auckland [DOI]

Cited by 0

No indexed citations yet.

Article metrics

Real usage data collected on this platform.

32

Page views

0

PDF downloads

4

Outbound clicks

0

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.